Acutus Medical announced a realignment of resources and operational downsizing resulting in a 70% workforce reduction.

Acutus Medical宣布重新调整资源和业务精简，导致劳动力减少70%。

Dr. Shaden Marzouk, the company’s board chair, called the downsizing “hard but necessary steps” in a news release. The company intends to continue to comply with its remaining obligations to Medtronic for the production of left-heart access products. Acutus sold its left-heart access portfolio to Medtronic for $50 million..

该公司董事会主席沙登·马尔祖克博士在新闻稿中称裁员是“艰难但必要的步骤”。该公司打算继续履行其对美敦力的剩余义务，生产左心通路产品。Acutus以5000万美元的价格将其左心接入投资组合出售给美敦力。。

Just over a year ago, Acutus announced plans to lay off 65% of its workforce, totaling roughly 160 employees. Earlier this year, the company was also delisted from the Nasdaq market.

就在一年多前，Acutus宣布计划裁员65%，总计约160名员工。今年早些时候，该公司也从纳斯达克市场摘牌。

Before enacting those layoffs, at the end of 2023, the company reported 230 full-time employees on board. Following the 160-person headcount reduction, the company likely had around 70 remaining employees, meaning the latest cuts affect approximately 50 employees.

在实施这些裁员之前，截至2023年底，该公司报告称有230名全职员工。在裁员160人之后，该公司可能还有大约70名剩余员工，这意味着最近的裁员将影响大约50名员工。

The reduced operations are designed to solely support the manufacturing and distribution of Medtronic’s left-heart access products. Acutus expects its actions to meaningfully reduce cash burn and ongoing operating expenses. It anticipates the completion of the reduction in the first quarter of 2025.

减少的运营旨在完全支持美敦力左心接入产品的制造和分销。Acutus预计其行动将有意义地减少现金消耗和持续运营费用。预计2025年第一季度完成减排。

The company plans to continue manufacturing for Medtronic until it fulfills its obligations under their purchase agreement..

该公司计划继续为美敦力制造，直到其履行其采购协议项下的义务。。

“The operational downsizing impacts our team, and it is difficult to part with our valued and highly talented colleagues who have made substantial contributions to our company,” said Takeo Mukai, CEO & CFO of Acutus. I want to thank each one of them for their dedication to Acutus and our mission.”

Acutus首席执行官兼首席财务官Takeo Mukai表示：“运营规模的缩减影响了我们的团队，很难与我们宝贵且才华横溢的同事分开，他们为我们的公司做出了巨大贡献。”。我要感谢他们每个人对Acutus和我们的使命的奉献。”

The financial impact of the Acutus downsizing

Acutus裁员的财务影响

Acutus anticipates approximately $1.4 million to $1.8 million in pre-tax downsizing and exit-related charges. Approximately $300,000 of that represents future cash expenditures for related consideration and costs. Additionally, around $1.2 million represents future expenditures for retention bonuses to certain employees set to assist with the downsizing.

Acutus预计税前裁员和退出相关费用约为140万至180万美元。其中约30万美元是相关对价和费用的未来现金支出。此外，约120万美元是未来为帮助裁员而向某些员工发放留任奖金的支出。

Finally, up to $300,000 could potentially go toward contract closing costs..

最后，高达30万美元的潜在合同关闭成本。。

The company expects the majority of the charges to come in the first quarter of 2025.

该公司预计大部分费用将在2025年第一季度支付。

Acutus plans for its exclusive source of revenue to continue to come from its Medtronic deal. It plans to utilize operating expenses and working capital to support operations related to that, plus general and administrative functions. The company intends to continue minimizing costs while picking up potential earnout payments from Medtronic..

Acutus计划继续从美敦力的交易中获得独家收入。该公司计划利用运营费用和营运资金支持与此相关的运营，以及一般和行政职能。该公司打算继续将成本降至最低，同时从美敦力获得潜在的盈利。。

Acutus remains eligible to receive additional earnouts based on a percentage of Medtronic’s total net end-user sales of the related products. That eligibility stretches to January 2027.

Acutus仍有资格根据美敦力相关产品总净最终用户销售额的百分比获得额外收益。该资格将延长至2027年1月。

As of Sept. 30, 2024, the company had $12.6 million in cash, equivalents, marketable securities and restricted cash. It expects that cash on hand, plus Medtronic-related revenue and earnouts, to service outstanding debt and fund the remaining business.

截至2024年9月30日，该公司拥有1260万美元的现金、等价物、有价证券和限制性现金。。